082270 — GemVax & KAEL Co Balance Sheet

0.000.00%

Last trade - 00:00

TechnologyHighly SpeculativeMid CapNeutral

Annual balance sheet for GemVax & KAEL Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	ARS	ARS	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	31,798	39,112	17,000	3,575	21,080
Net Total Accounts Receivable
Net Total Receivables	7,008	4,106	4,993	11,075	6,962
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	52,612	60,136	33,731	25,166	42,915
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	26,343	32,480	37,498	36,551	33,000
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	172,338	151,143	135,153	150,746	158,875
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	16,140	15,824	25,989	70,270	65,437
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	18,352	16,792	27,135	121,740	101,646
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	153,986	134,351	108,019	29,006	57,229
Total Liabilities & Shareholders' Equity	172,338	151,143	135,153	150,746	158,875
Total Common Shares Outstanding